Summary of the Sequence Analysis and the Assessment of Intraclonal Heterogeneity of the Three Cases
Patient . | Biopsy . | VH Family . | Germ-line (GL) Donor . | D-Segment Gene . | JH-Gene . | TumorDerived/ Total B-Cell Sequences . | Intraclonal Heterogeneity . | No. of Different but Clonally Related Sequences . | % Homology of Dominant Sequence to GL . | Range of % Homology to GL . |
---|---|---|---|---|---|---|---|---|---|---|
BA | 1F | VH1 | VI-4.1.b | D5 | JH4b | 23/25 | Yes | 16 | 93.1 | 92.4-93.8 |
2P | VH1 | VI-4.1.b | D5 | JH4b | 8/24 | Yes | 3 | 93.4 | 91.6-93.4 | |
EJ | 1F | VH3 | V3-7 | D21-9 | JH3a | 21/28 | Yes | 4 | 93.7 | 93.7-94.4 |
2F | VH3 | V3-7 | D21-9 | JH3a | 16/19 | Yes | 11 | 94.8 | 94.3-94.8 | |
3F | VH3 | V3-7 | D21-9 | JH3a | 23/25 | Yes | 9 | 94.2 | 92.4-95.5 | |
BR | 1P | VH3 | V3-30.5 | DXP5a | JH4b | 9/10 | Yes | 4 | 84.6 | 83.6-84.6 |
2F | VH3 | V3-30.5 | DXP5a | JH4b | 9/12 | No | 1 | 86.7* | Homogeneous |
Patient . | Biopsy . | VH Family . | Germ-line (GL) Donor . | D-Segment Gene . | JH-Gene . | TumorDerived/ Total B-Cell Sequences . | Intraclonal Heterogeneity . | No. of Different but Clonally Related Sequences . | % Homology of Dominant Sequence to GL . | Range of % Homology to GL . |
---|---|---|---|---|---|---|---|---|---|---|
BA | 1F | VH1 | VI-4.1.b | D5 | JH4b | 23/25 | Yes | 16 | 93.1 | 92.4-93.8 |
2P | VH1 | VI-4.1.b | D5 | JH4b | 8/24 | Yes | 3 | 93.4 | 91.6-93.4 | |
EJ | 1F | VH3 | V3-7 | D21-9 | JH3a | 21/28 | Yes | 4 | 93.7 | 93.7-94.4 |
2F | VH3 | V3-7 | D21-9 | JH3a | 16/19 | Yes | 11 | 94.8 | 94.3-94.8 | |
3F | VH3 | V3-7 | D21-9 | JH3a | 23/25 | Yes | 9 | 94.2 | 92.4-95.5 | |
BR | 1P | VH3 | V3-30.5 | DXP5a | JH4b | 9/10 | Yes | 4 | 84.6 | 83.6-84.6 |
2F | VH3 | V3-30.5 | DXP5a | JH4b | 9/12 | No | 1 | 86.7* | Homogeneous |
*The frozen biopsy specimen BR-2F yielded longer sequence than the earlier biopsy 1P, with comparatively fewer mutations in FWR1. This leads to an apparent increase of homology to the germline sequence in the later biopsy.